Healthcare Scan

Scan

Healthcare Scan

raw scan snapshot — prices as of scan date, not live 36 rows · screens, not recommendations prior scanresearch/scans/2026-08-28-healthcare-scan.md

Healthcare stays broadly healthy — the same twelve names that carried a clean uptrend two scans ago still do, unchanged for a third straight scan. But $SYK crashed into the oversold band this scan (RSI 49.2 to 34.1, a 15.1-point drop, the cut's largest single-name move) even as $CVS climbed fully out of it (37.9 to 49.5) with its long-trend numbers still clean. $ABT's cooldown from an overbought squeeze two scans ago has turned into a genuine decline (59.6 to 47.3) with its year-over-year return getting worse, not better. $ZTS remains the cut's deepest breakdown by a wide margin and $ISRG continues its relapse for a fifth straight scan, while $HROW's long trend actually improved — its year-over-year return flipped positive even though it's still testing its 200-day from below.

Data as-of the 2026-09-04 close (Friday's settled session) — every name in this cut carries a fresh bar this scan.

Source: healthcare.json (the broader universe, not the narrower healthcare-scan.json cut — consistent with the prior scan). Prior scan: 2026-08-28-healthcare-scan.

Quick Snapshot

Signal Reading
Overall 🟢 Broadly healthy — the same twelve-name uptrend core holds for a third straight scan — but $SYK crashed newly into the oversold band while $CVS climbed fully out
Leaders $GILD (RSI 67.7, the cut's highest print, flat from last scan); $VEEV (65.9, cooled from being the most overbought but still a weak long trend underneath)
Laggards $SYK (34.1, crashed newly into the oversold band, the cut's largest single-name move); $ISRG (43.0, fifth straight scan below its 200-day); $HROW (46.4, recovering)
Key insight $SYK's 15.1-point RSI drop is the cut's sharpest move this scan, and its long-trend numbers worsened alongside it — year-over-year return -15.1% → -23.1%, vs-200-day -2.7% → -10.4%

What's Going On

The cohort's core uptrend group is unchanged for a third straight scan: $BIIB, $LLY, $JNJ, $GH, $GILD, $VRTX, $XLV, $DXCM, $PFE, $AMGN, $TMO, and $MRK all remain above their 200-day average with a strongly positive year-over-year return, the same twelve names that have anchored the "broadly strong" read across the last three scans.

$SYK is this scan's clearest casualty. It dropped from RSI 49.2 to 34.1 — a 15.1-point decline, the cut's largest single-name move — on a 8.3% weekly decline, and its long-trend numbers got worse alongside the RSI drop: year-over-year return fell from -15.1% to -23.1%, and it's now 10.4% below its 200-day, versus 2.7% two scans ago. This is a genuine deterioration, not a rough week inside an otherwise intact trend.

$ABT's story continues to worsen rather than stabilize. Two scans ago it cooled off an overbought squeeze (RSI 77.8 to 59.6); this scan it kept falling, down to 47.3, while its year-over-year return also got worse (-14.4% to -18.4%) even as its price sits just 1.9% above its 200-day. That combination — RSI still falling, long-trend numbers still deteriorating — is the pattern to watch here, not a name that's found its floor. $VEEV, which took over $ABT's overbought-but-weak-trend flag last scan, cooled meaningfully this scan (74.9 to 65.9) but the underlying trend read hasn't changed: still barely positive on the year (+1.9%) with a badly negative alpha (-16.8) despite comfortably clearing its 200-day (+38.5%).

$CVS is the clean positive story this scan: it climbed fully out of the oversold band (37.9 to 49.5) while its long-trend numbers kept improving — year-over-year return now +31.3% (from +29.0%), 11.8% above its 200-day (from +8.1%). That's a deep pullback resolving upward, not a name that needed the oversold reading to look interesting. $HROW also improved on the fundamentals even though its RSI (46.4) is still soft: its year-over-year return flipped from -4.4% to +6.5%, though it remains 6.7% below its 200-day — call this "recovering, still testing the 200-day from below" rather than a clean breakdown anymore.

$ZTS remains the cleanest long-trend breakdown in the cut, and it's essentially unchanged at the worst level: down 50.5% over the past year, 26.4% below its 200-day average, with an alpha of -69.2. RSI sits at 48.8 — still mid-range, still not obviously alarming on its own — which is exactly why the long-trend check matters here more than anywhere else in this cut. $ISRG continues the relapse pattern flagged across the past four scans, now a fifth straight scan below its 200-day (-20.9%) with a negative year-over-year return (-19.3%), essentially unchanged from two scans ago.

What Changed Since Prior Scan (2026-08-28)

  • $SYK crashed into the oversold band, the cut's sharpest move this scan. RSI 49.2 → 34.1 (-15.1), price down 8.3% for the week — year-over-year return worsened from -15.1% to -23.1%, vs-200-day from -2.7% to -10.4%.
  • $CVS climbed fully out of the oversold band. RSI 37.9 → 49.5 (+11.6), year-over-year return improved to +31.3% (from +29.0%) — a deep pullback resolving upward.
  • $ABT's cooldown became a genuine decline. RSI 59.6 → 47.3 (-12.3), with the underlying trend getting worse, not better (1-year return -14.4% → -18.4%).
  • $VEEV cooled off the cut's overbought spot. RSI 74.9 → 65.9 (-9.0), still barely positive on the year (+1.9%) with negative alpha.
  • $HROW's long-trend numbers improved even as its RSI stayed soft. RSI 39.5 → 46.4 (+6.9), year-over-year return flipped from -4.4% to +6.5% — no longer a clean breakdown, though still 6.7% below its 200-day.
  • $TMO cooled from extended. RSI 66.2 → 57.4 (-8.8), still up 25.4% over the year.
  • $JNJ and $UNH both firmed modestly. JNJ: 56.0 → 60.6 (+4.6). UNH: 42.3 → 46.8 (+4.5), still above its 200-day with a positive year.
  • $ISRG continues its relapse for a fifth straight scan — 1-year return -21.4% → -19.3% (slightly better), vs-200-day -20.5% → -20.9% (slightly worse), essentially unchanged.
  • $ZTS remains essentially unchanged at the cut's deepest breakdown — -50.0% → -50.5% on the year, still the widest gap to its 200-day in the cut.
  • No stale bars this scan — every name carries a fresh 2026-09-04 close.
  • Universe unchanged. Same 22 tickers as the prior scan.

How To Read The Board

RSI measures how stretched a stock is over the past 14 sessions — under 30 signals oversold, over 70 signals overbought/extended. vs SMA20 is the price gap to the 20-day average. 1Y% and vs SMA200 are the two numbers that separate a genuine breakdown from a pullback: $CVS looks weak on RSI history but is above its 200-day with a positive and improving year — a deep pullback resolving upward, not a breakdown. $ZTS, $ISRG, $SYK, and $ABT are below (or barely above, for $ABT) their 200-day with a negative year, and the long-trend numbers on all four got worse this scan even where the RSI didn't collapse — genuine deterioration, regardless of a mid-range RSI. $VEEV is the trickiest read again this scan: cooled on RSI but still barely positive on the year with a negative alpha — don't let the RSI cooldown read as the trend catching up.

Price Table

Stock Price RSI SMA20 vs SMA20 7D% 30D% 1Y% vs SMA200 Signal
SYK $303.13 34.1 $329.35 -8.0% -8.3% -10.1% -23.1% -10.4% 🔴 Crashed in, breakdown deepening
LLY $1,149.36 41.3 $1,202.60 -4.4% -2.1% -1.8% +54.7% +8.1% 🟢 Healthy
ISRGE $366.70 43.0 $381.71 -3.9% -1.6% -2.3% -19.3% -20.9% 🔴 Breakdown, 5th straight scan
HROW $38.54 46.4 $39.40 -2.2% +3.4% -2.2% +6.5% -6.7% 🟡 Recovering, still below 200-day
UNH $397.14 46.8 $396.91 +0.1% +1.1% -3.8% +28.0% +13.0% 🟡 Deep pullback, intact
ABT $108.33 47.3 $111.89 -3.2% -3.7% +2.5% -18.4% +1.9% 🔴 Decline deepening, weak 1Y
ZTS $75.81 48.8 $75.83 0.0% -2.0% +1.9% -50.5% -26.4% 🔴 Breakdown, worst in cut
CVS $96.74 49.5 $94.76 +2.1% +4.0% -2.4% +31.3% +11.8% 🟢 Cleared, deep pullback resolving
GH $161.41 50.2 $163.79 -1.5% -0.1% -1.1% +163.1% +37.5% 🟢 Healthy
DXCM $87.90 52.9 $89.89 -2.2% -3.2% +6.3% +8.8% +24.0% 🟢 Healthy
XLV $171.45 55.5 $171.31 +0.1% +0.2% +4.4% +24.8% +10.3% 🟢 Healthy (sector ETF)
TMO $613.78 57.4 $611.93 +0.3% -1.3% +6.2% +25.4% +14.5% 🟢 Healthy
BIIB $220.83 58.0 $215.77 +2.3% +1.1% +6.9% +57.8% +15.6% 🟢 Healthy
VRTX $546.12 59.4 $538.78 +1.4% +0.8% +12.6% +37.6% +17.2% 🟢 Healthy
JNJ $275.23 60.6 $268.27 +2.6% +2.7% +6.9% +54.0% +16.7% 🟢 Healthy
MRK $150.33 62.3 $145.03 +3.7% +1.4% +17.1% +78.9% +27.0% 🟠 Extended, healthy
AMGN $437.23 62.5 $430.34 +1.6% +1.1% +7.8% +56.1% +23.4% 🟢 Healthy
PFE $28.45 62.5 $27.80 +2.4% +1.8% +10.2% +15.9% +8.7% 🟠 Extended, healthy
MRNA $145.55 63.2 $117.96 +23.4% +5.5% +158.7% +499.5% +165.5% 🟠 Extreme move, high-variance
MDT $94.17 64.5 $91.73 +2.7% +3.3% +9.5% +1.4% +5.0% 🔴 Flat 1Y, weak alpha
VEEV $275.09 65.9 $257.19 +7.0% -0.5% +28.8% +1.9% +38.5% 🔴 Cooled, still weak 1Y
GILD $151.00 67.7 $144.35 +4.6% +3.6% +14.6% +33.9% +12.4% 🟢 Healthy

Tier Analysis

Extreme Oversold (RSI < 25)

None.

Oversold (RSI 25-40)

$SYK (34.1) — the only name in the band, replacing $CVS and $HROW who both climbed out this scan. $SYK's long-trend numbers deteriorated alongside its RSI, making this a genuine breakdown rather than a buy-the-dip setup.

RSI 40+ (everyone else)

  • Genuine breakdown, deteriorating (below or barely above 200-day, negative 1-year, trend getting worse): $ISRG, $ABT, $ZTS — three names; $ZTS is the deepest of the group by a wide margin, essentially unchanged from the prior scan, while $ABT's numbers worsened this scan specifically.
  • Recovering, still below the 200-day: $HROW — the year-over-year return flipped positive this scan even though price remains below the 200-day.
  • Flat 1-year despite mid-range RSI: $MDT — technically above its 200-day but flat on the year with weak alpha.
  • Overbought but long-trend weak: $VEEV — the cut's highest RSI two scans ago, now cooling, but still barely positive on the year with negative alpha.
  • Extreme, high-variance move: $MRNA — up 499.5% over the year, a distinct situation from the rest of the cut.
  • Genuinely healthy uptrend: $LLY, $UNH, $GH, $DXCM, $XLV, $TMO, $BIIB, $VRTX, $JNJ, $MRK, $AMGN, $PFE, $GILD — thirteen names, the bulk of the cut, all above their 200-day with a strongly positive year, unchanged from the prior scan.
  • Deep pullback but intact, resolving upward: $CVS — weak RSI history this scan but above the 200-day with an improving positive year.

Entry Zones

Stock Price Zone RSI 1Y% Setup
CVS $96.74 Shelf at $78.94 49.5 +31.3% Just climbed out of the oversold band with improving long-trend numbers — deep pullback resolving upward
UNH $397.14 <$363.08 (support shelf) 46.8 +28.0% Modest RSI but still up 28% over the year and above its 200-day
GILD $151.00 <$135.93 (support shelf) 67.7 +33.9% Not extended despite the RSI; healthy long trend
SYK $303.13 No support shelf identified 34.1 -23.1% Just crashed into the oversold band with worsening long-trend numbers — no confirmed floor
ZTS $75.81 No support shelf identified 48.8 -50.5% The cut's clearest breakdown by a wide margin — no confirmed floor, avoid treating the mid-range RSI as a buy signal

Action Matrix

Action Stocks Why
🔒 HOLD LLY, GH, DXCM, XLV, TMO, BIIB, VRTX, JNJ, MRK, AMGN, PFE, GILD Above the 200-day with a strongly positive year-over-year return — the cleanest reads in the cut, unchanged for three straight scans
📈 ACCUMULATE CVS, UNH Both pass the long-trend test with improving or steady positive year-over-year returns inside an intact uptrend
🔍 WATCH HROW Long-trend numbers improved this scan even though price is still below its 200-day — confirm whether this becomes a genuine recovery
⚠️ AVOID / DON'T CHASE VEEV, MRK, PFE, MRNA $VEEV is still the extended-but-weak name; $MRK/$PFE are extended but otherwise healthy; $MRNA is an extreme, high-variance single-name move
❌ AVOID / BREAKDOWN WATCH SYK, ISRG, ABT, ZTS Below (or barely above) the 200-day with a negative year-over-year return that got worse, not better, this scan — genuine long-trend breakdowns, $ZTS by the widest margin

What To Watch Next

  • $SYK just crashed into the oversold band with worsening long-trend numbers — does it stabilize, or does this become the next multi-scan relapse pattern like $ISRG's?
  • $ABT's cooldown from overbought has turned into an outright decline with a worsening 1-year return — does it find a floor, or does the deterioration continue?
  • $ISRG is below its 200-day for a fifth straight scan — does the relapse finally break, or continue a sixth time?
  • $HROW's long-trend numbers improved this scan even with a soft RSI — does the price confirm the recovery next, or does it stay stuck below its 200-day?

Sources

  • Tape data (price/RSI/SMA/returns): full-scan pre-computed summaries as of the 2026-09-04 close — healthcare.
  • Prior scan for comparison: 2026-08-28-healthcare-scan.
10 events

No direct external sources are attached to this read.